© Drug Hunter Inc. 2018-2022
Home > MLT-985
<< Back to November 2020
allosteric MALT1 protease (paracaspase) inh.
oral QD act. in xenograft; on-target pathology
from 1M cmpd biochem. HTS and opt.
J. Med. Chem., Nov. 20, 2020
Novartis, Basel, CH
MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)
Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: